Literature DB >> 8675745

Lymphocyte infiltration in oesophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and grade.

J C Rockett1, S J Darnton, J Crocker, H R Matthews, A G Morris.   

Abstract

Infiltration by T lymphocytes into oesophageal carcinomas was assessed immunohistochemically, total T lymphocyte numbers by staining for CD3 and activated T lymphocytes by staining for CD25. Five squamous carcinomas and seven adenocarcinomas, resected without neoadjuvant treatment, were studied. Computer aided quantitation showed that total numbers of tumour infiltrating CD3 positive cells were highly variable (range 48-1673 cells/mm2). They were located largely in the stromal (87.9-99.2%) rather than intratumoral regions. Up to 84% of tumour infiltrating T lymphocytes were CD25 positive, although the median figure was 33%. There was no correlation between T lymphocyte infiltration or activation and expression of class I and II histocompatibility antigens, intercellular adhesion molecule-1, tumour stage or grade. These results imply that the local inflammatory response in oesophageal carcinomas is deregulated, which may be a factor contributing to the aggressive nature of the tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675745      PMCID: PMC500414          DOI: 10.1136/jcp.49.3.264

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

Review 1.  The role of ICAM-1 in tumor development.

Authors:  J P Johnson
Journal:  Chem Immunol       Date:  1991

Review 2.  Natural history of HLA expression during tumour development.

Authors:  F Garrido; T Cabrera; A Concha; S Glew; F Ruiz-Cabello; P L Stern
Journal:  Immunol Today       Date:  1993-10

3.  HLA class II antigen expression in human papillomavirus-associated cervical cancer.

Authors:  S S Glew; M Duggan-Keen; T Cabrera; P L Stern
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

4.  Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.

Authors:  A M Nouri; R F Hussain; R T Oliver; A M Handy; I Bartkova; J G Bodmer
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

5.  Simultaneous detection of intercellular adhesion molecule-1 (CD54) and carcinoembryonic antigen in lung adenocarcinoma.

Authors:  A Nonomura; Y Mizukami; J Shimizu; Y Hayashi; S Murakami; Y Watanabe; R Kamimura; T Takashima
Journal:  Mod Pathol       Date:  1994-02       Impact factor: 7.842

6.  Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma.

Authors:  J C Rockett; S J Darnton; J Crocker; H R Matthews; A G Morris
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

7.  Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma.

Authors:  S Vesalainen; P Lipponen; M Talja; K Syrjänen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

  7 in total
  3 in total

1.  Palatine tonsillar metastasis of a small pulmonary adenocarcinoma showing an invasive micropapillary carcinoma pattern and Pagetoid spread at the tonsil: a case suggesting retrograde lymphatic metastasis from bulky lymph node metastases of the neck.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients.

Authors:  Kimitaka Tanaka; Takahiro Tsuchikawa; Masaki Miyamoto; Takehiro Maki; Masaomi Ichinokawa; Kanako C Kubota; Toshiaki Shichinohe; Satoshi Hirano; Soldano Ferrone; Hirotoshi Dosaka-Akita; Yoshihiro Matsuno; Satoshi Kondo
Journal:  Int J Oncol       Date:  2011-11-30       Impact factor: 5.650

3.  Retrograde Lymphatic Spread of Esophageal Cancer: A Case Report.

Authors:  Hisashi Oshiro; Yoshiaki Osaka; Shingo Tachibana; Takaya Aoki; Takayoshi Tsuchiya; Toshitaka Nagao
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.